{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:39:05Z","timestamp":1761100745760},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,2,23]],"date-time":"2005-02-23T00:00:00Z","timestamp":1109116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00277-004-1003-3","type":"journal-article","created":{"date-parts":[[2005,2,22]],"date-time":"2005-02-22T10:24:45Z","timestamp":1109067885000},"page":"462-473","source":"Crossref","is-referenced-by-count":8,"title":["Long-term results of autologous stem cell transplantation for Hodgkin\u2019s disease (HD) and low-\/intermediate-grade B non-Hodgkin\u2019s lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR)"],"prefix":"10.1007","volume":"84","author":[{"given":"David","family":"Nachbaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard T.","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Koller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Linkesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedwig","family":"Kasparu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Hinterberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Hausmaninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Heistinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Ulsperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Karlhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Schwinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"1003_CR1","first-page":"1933","volume":"92","author":"M Andr\u00e9","year":"1998","unstructured":"Andr\u00e9 M, Henry-Amar M, Blaise D, Colombat P, Fleury J, Milpied N, Cahn JY, Pico JL, Bastion Y, Kuentz M, Nedellec G, Attal M, Ferme C, Gisselbrecht C (1998) Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin\u2019s disease. Blood 92:1933\u20131940","journal-title":"Blood"},{"key":"1003_CR2","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood.V86.8.3257.3257","volume":"86","author":"Y Bastion","year":"1995","unstructured":"Bastion Y, Brice P, Haioun C, Sonet A, Salles G, Marolleau J, Espinouse D, Reyes F, Gisselbrecht C, Coiffier B (1995) Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 86:3257\u20133262","journal-title":"Blood"},{"key":"1003_CR3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1200\/JCO.1997.15.2.445","volume":"15","author":"P Bierman","year":"1997","unstructured":"Bierman P, Vose J, Anderson J, Bishop M, Kessinger A, Armitage J (1997) High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin\u2019s Lymphoma. J Clin Oncol 15:445\u2013450","journal-title":"J Clin Oncol"},{"key":"1003_CR4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1023\/A:1008343823292","volume":"10","author":"P Brice","year":"1999","unstructured":"Brice P, Divine M, Simon D, Coiffier B, Leblond V, Simon M, Voilat L, Devidas A, Morschhauser F, Rohrlich P, Andre M, Lepage E, Ferme C (1999) Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavourable relapse from Hodgkin\u2019s disease (HD). SFGM\/GELA Study Group. Ann Oncol 10:1485\u20131488","journal-title":"Ann Oncol"},{"key":"1003_CR5","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1994.12.12.2527","volume":"12","author":"DL Darrington","year":"1994","unstructured":"Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, Weisenburger DD, Kessinger A, Armitage JO (1994) Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527\u20132534","journal-title":"J Clin Oncol"},{"key":"1003_CR6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bmt.1701981","volume":"24","author":"O Fitoussi","year":"1999","unstructured":"Fitoussi O, Simon D, Brice P, Makke J, Scrobohaci ML, Bibi Triki T, Hennequin C, Ferme C, Gisselbrecht C (1999) Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkin\u2019s disease or non-Hodgkin\u2019s lymphoma. Bone Marrow Transplant 24:747\u2013755","journal-title":"Bone Marrow Transplant"},{"key":"1003_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.1998.16.1.13","volume":"16","author":"AS Freedman","year":"1998","unstructured":"Freedman AS, Neuberg D, Gribben JG, Mauch P, Soiffer RJ, Fisher DC, Anderson KC, Andersen N, Schlossman R, Kroon M, Ritz J, Aster J, Nadler LM (1998) High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle cell lymphoma: no evidence for long-term remission. J Clin Oncol 16:13\u201318","journal-title":"J Clin Oncol"},{"key":"1003_CR8","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","volume":"94","author":"A Freedman","year":"1999","unstructured":"Freedman A, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC, Schlossmann R, Alyea EP, Takvorian T, Jallow H, Kuhlman C, Ritz J, Nadler LM, Gribben JG (1999) Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 94:3325\u20133333","journal-title":"Blood"},{"key":"1003_CR9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2002-08-2476","volume":"102","author":"AM Gianni","year":"2003","unstructured":"Gianni AM, Magni M, Martelli M, Di Nicola M, Carlo-Stella C, Pilotti S, Rambaldi A, Cortelazzo S, Patti C, Parvis G, Benedetti F, Capria S, Corradini P, Tarella C, Barbui T (2003) Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood 102:749\u2013755","journal-title":"Blood"},{"key":"1003_CR10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00277-002-0495-y","volume":"81","author":"JP Glossmann","year":"2002","unstructured":"Glossmann JP, Josting A, Pfistner B, Paulus U, Engert A, German Hodgkin\u2019s Lymphoma Study Group (GHSG) (2002) A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin\u2019s disease (HD-R2). Ann Hematol 81:424\u2013429","journal-title":"Ann Hematol"},{"key":"1003_CR11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representation of old estimators. Stat Med 18:695\u2013706","journal-title":"Stat Med"},{"key":"1003_CR12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.V89.3.801","volume":"89","author":"SJ Horning","year":"1997","unstructured":"Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Long GD, Hu WW, Wong RM, Brown BW, Blume KG (1997) High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin\u2019s disease: analysis of the Stanford University results and prognostic indices. Blood 89:801\u2013813","journal-title":"Blood"},{"key":"1003_CR13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood.V96.4.1280","volume":"96","author":"A Josting","year":"2000","unstructured":"Josting A, Rueffer U, Franklin J, Sieber M, Diehl V, Engert A (2000) Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. Blood 96:1280\u20131286","journal-title":"Blood"},{"key":"1003_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"1003_CR15","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Romaguera J, Kantarjian H, Palmer JL, Pugh WC, Korbling M, Hagemeister F, Samuels B, Rodriguez A, Giralt S, Younes A, Przepiorka D, Claxton D, Cabanillas F, Champlin R (1998) Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem cell transplantation: an active regimen for aggressive mantle cell lymphoma. J Clin Oncol 16:3803\u20133809","journal-title":"J Clin Oncol"},{"key":"1003_CR16","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2002-02-0621","volume":"100","author":"M Ladetto","year":"2002","unstructured":"Ladetto M, Corradini P, Vallet S, Benedetti F, Vitolo U, Martelli M, Brugiatelli M, Coser P, Perrotti A, Majolino I, Fioritoni G, Morandi S, Musso M, Zambello R, Chisesi T, Di Renzo N, Vivaldi P, De Creszenzo A, Gallamini A, Salvi F, Santini G, Boccomini C, Sorio M, Astolfi M, Drandi D, Pileri A, Tarella C (2002) High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood 100:1559\u20131565","journal-title":"Blood"},{"key":"1003_CR17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1200\/JCO.1999.17.2.534","volume":"17","author":"HM Lazarus","year":"1999","unstructured":"Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM (1999) Autotransplants for Hodgkin\u2019s disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 17:534\u2013545","journal-title":"J Clin Oncol"},{"key":"1003_CR18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1702796","volume":"27","author":"HM Lazarus","year":"2001","unstructured":"Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM (2001) Autotransplants for Hodgkin\u2019s disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant 27:387\u2013396","journal-title":"Bone Marrow Transplant"},{"key":"1003_CR19","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2004-03-0982","volume":"104","author":"G Lenz","year":"2004","unstructured":"Lenz G, Dreyling M, Schiegnitz E, Forstpointner R, Wandt H, Freund M, Hess G, Truemper L, Diehl V, Kropff M, Kneba M, Schmitz N, Metzner B, Pfirrmann M, Unterhalt M, Hiddemann W (2004) Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma\u2014results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). Blood 104:2667\u20132674","journal-title":"Blood"},{"key":"1003_CR20","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","volume":"341","author":"DC Linch","year":"1993","unstructured":"Linch DC, Winfield D, Goldstone AH, Moir D, Hancock B, McMillan A, Chopra R, Milligan D, Hudson GV (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin\u2019s disease: results of a BNLI randomised trial. Lancet 341:1051\u20131054","journal-title":"Lancet"},{"key":"1003_CR21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2141.1999.01627.x","volume":"106","author":"DW Milligan","year":"1999","unstructured":"Milligan DW, Ruiz De Elvira C, Kolb HJ, Goldstone AH, Meloni G, Rohatiner AZ, Colombat P, Schmitz N (1999) Secondary leukemia and myelodysplasia after autografting for lymphoma: results from the EBMT. Br J Haematol 106:1020\u20131026","journal-title":"Br J Haematol"},{"key":"1003_CR22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bmt.1701400","volume":"22","author":"N Milpied","year":"1998","unstructured":"Milpied N, Gaillarde F, Moreau P, Mah\u00e9 B, Souchet J, Rapp MJ, Bulabois CE, Morineau N, Harousseau JL (1998) High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience. Bone Marrow Transplant 22:645\u2013650","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"1003_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/annonc\/9.suppl_1.S15","volume":"9","author":"N Mounier","year":"1998","unstructured":"Mounier N, Gisselbrecht C (1998) Conditioning regimens before transplantation in patients with aggressive non-Hodgkin\u2019s lymphoma. Ann Oncol 9 [Suppl 1]:15\u201321","journal-title":"Ann Oncol"},{"key":"1003_CR24","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn J-Y, Harousseau J-L, Cioffier B, Biron P, Mandelli F, Chauvin F (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med 333:1540\u20131545","journal-title":"N Engl J Med"},{"key":"1003_CR25","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.V73.8.2086.2086","volume":"73","author":"GL Phillips","year":"1989","unstructured":"Phillips GL, Wolff SN, Herzig RH, Lazarus HM, Fay JW, Lin HS, Shina DC, Glasgow GP, Griffith RC, Lamb CW, Herzig GP (1989) Treatment of progressive Hodgkin\u2019s disease with intensive chemoradiotherapy and autologous bone marrow transplantation. Blood 73:2086\u20132092","journal-title":"Blood"},{"key":"1003_CR26","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1182\/blood-2001-11-0107","volume":"100","author":"SP Robinson","year":"2002","unstructured":"Robinson SP, Goldstone AH, Mackinnon S, Carella A, Russell N, Ruiz de Elvira C, Taghipour G, Schmitz N (2002) Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood 100:4310\u20134316","journal-title":"Blood"},{"key":"1003_CR27","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1994.12.6.1177","volume":"12","author":"A Rohatiner","year":"1994","unstructured":"Rohatiner A, Johnson P, Price C, Arnott SJ, Amess J, Norton A, Dorey E, Adams K, Whelan J, Matthews J, MacCallum P, Oza A, Lister T (1994) Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 12:1177\u20131184","journal-title":"J Clin Oncol"},{"key":"1003_CR28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1702795","volume":"27","author":"A Salar","year":"2001","unstructured":"Salar A, Sierra J, Gandarillas M, Caballero MD, Mar\u00edn J, Lahuerta JJ, Garc\u00eda-Conde J, Arranz R, Le\u00f3n A, Zuazu J, Garc\u00eda-Lara\u00f1a J, L\u00f3pez-Guillermo A, Sanz MA, Gra\u00f1ena A, Garc\u00eda JC, Conde E, for the GEL\/TAMO Spanish Cooperative Group (2001) Autologous stem cell transplantation for clinically aggressive non-Hodgkin\u2019s lymphoma: the role of preparative regimens. Bone Marrow Transplant 27:405\u2013412","journal-title":"Bone Marrow Transplant"},{"key":"1003_CR29","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","volume":"359","author":"N Schmitz","year":"2002","unstructured":"Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M, Boissevain F, Zschaber R, M\u00fcller P, Kirchner H, Lohri A, Decker S, Koch B, Hasenclever Goldstone AH, Diehl V, for the German Hodgkin\u2019s Lymphoma Study Group (GHSG), the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin\u2019s disease: a randomised trial. Lancet 359:2065\u20132071","journal-title":"Lancet"},{"key":"1003_CR30","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","volume":"21","author":"HC Schouten","year":"2003","unstructured":"Schouten HC, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnsen HE, Doorduijn JK, Sydes MR, Kvalheim G (2003) High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin\u2019s lymphoma: results from the randomized European CUP Trial. J Clin Oncol 21:3918\u20133927","journal-title":"J Clin Oncol"},{"key":"1003_CR31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","volume":"1","author":"A Stansfeld","year":"1988","unstructured":"Stansfeld A, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, van Unnik J, Wright D (1988) Updated Kiel classification of lymphomas. Lancet 1:292\u2013293","journal-title":"Lancet"},{"key":"1003_CR32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.bmt.1702541","volume":"26","author":"DA Stewart","year":"2000","unstructured":"Stewart DA, Guo D, Gluck S, Morris D, Chaudhry A, deMetz C, Klasssen J, Brown CB, Russell JA (2000) Double high-dose therapy for Hodgkin\u2019s disease with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant 26:383\u2013388","journal-title":"Bone Marrow Transplant"},{"key":"1003_CR33","first-page":"76","volume":"2","author":"KE Stockerl-Goldstein","year":"1996","unstructured":"Stockerl-Goldstein KE, Horning SJ, Negrin RS, Chao NJ, Hu WW, Long GD, Hoppe RT, Amylon MD, Brown BW Jr, Blume KG (1996) Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin\u2019s lymphoma. Biol Blood Marrow Transplant 2:76\u201385","journal-title":"Biol Blood Marrow Transplant"},{"key":"1003_CR34","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2001.19.5.1395","volume":"19","author":"A Sureda","year":"2001","unstructured":"Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, Garc\u00eda-Conde J, Jarque I, Cabllero MD, Ferr\u00e0 C, L\u00f3pez A, Garc\u00eda-Larana J, Cabrera R, Carrera D, Ruiz-Romero MD, Le\u00f3n A, Rif\u00f3n J, D\u00edaz-Mediavilla J, Mataix R, Morey M, Moraleda JM, Alt\u00e9s A, L\u00f3pez-Guillermo A, de la Serna J, Fern\u00e1ndez-Ranada JM, Sierra J, Conde E, for the Grupo Espanol de Linfomas\/Transplante Aut\u00f3logo de M\u00e9dula \u00d3sea Spanish Cooperative Group (2001) Autologous stem-cell transplantation for Hodgkin\u2019s disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas\/Transplante Aut\u00f3logo de M\u00e9dula \u00d3sea Spanish Cooperative Group. J Clin Oncol 19:1395\u20131404","journal-title":"J Clin Oncol"},{"key":"1003_CR35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bmt.1700963","volume":"20","author":"JW Sweetenham","year":"1997","unstructured":"Sweetenham JW, Taghipour G, Milligan D, Blystad AK, Caballero D, Fassas A, Goldstone AH, on behalf of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (1997) High-dose therapy and autologous stem cell rescue for patients with Hodgkin\u2019s disease in first relapse after chemotherapy: results from the EBMT. Bone Marrow Transplant 20:745\u2013752","journal-title":"Bone Marrow Transplant"},{"key":"1003_CR36","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.1999.17.10.3101","volume":"17","author":"JW Sweetenham","year":"1999","unstructured":"Sweetenham JW, Carella AM, Taghipour G, Cunningham D, Marcus R, Della Volpe A, Linch DC, Schmitz N, Goldstone AH (1999) High-dose therapy and autologous stem cell transplantation for adult patients with Hodgkin\u2019s disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. J Clin Oncol 17:3101\u20133109","journal-title":"J Clin Oncol"},{"key":"1003_CR37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1703255","volume":"28","author":"JW Sweetenham","year":"2001","unstructured":"Sweetenham JW (2001) Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials. Bone Marrow Transplant 28:813\u2013820","journal-title":"Bone Marrow Transplant"},{"key":"1003_CR38","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","author":"The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project","year":"1982","unstructured":"The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classification of non-Hodgkin\u2019s lymphomas. Summary and description of a Working Formulation for clinical usage. Cancer 49:2112\u20132135","journal-title":"Cancer"},{"key":"1003_CR39","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2003-04-1205","volume":"102","author":"K Besien Van","year":"2003","unstructured":"Van Besien K, Loberiza FR, Bajrunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora AL, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM (2003) Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood 102:3521\u20133529","journal-title":"Blood"},{"key":"1003_CR40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2141.2003.04140.x","volume":"120","author":"E Vandenberghe","year":"2003","unstructured":"Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, L\u00f3pez-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Besien K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N (2003) Outcome of autologous transplantation for mantle cell lymphoma: a study of the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. Br J Haematol 120:793\u2013800","journal-title":"Br J Haematol"},{"key":"1003_CR41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1083-8791(00)70030-9","volume":"6","author":"JM Vose","year":"2000","unstructured":"Vose JM, Bierman PJ, Weisenberger DD, Lynch JC, Bociek Y, Chan WC, Greiner TC, Armitage JO (2000) Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant 6:640\u2013645","journal-title":"Biol Blood Marrow Transplant"},{"key":"1003_CR42","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.1993.11.7.1329","volume":"11","author":"CH Weaver","year":"1993","unstructured":"Weaver CH, Appelbaum FR, Petersen FB, Clift R, Singer J, Press O, Bensinger W, Bianco J, Martin P, Anasetti C, Badger C, Deeg J, Dony K, Hansen JA, Petersdorf E, Ronley S, Storb R, Sullivan K, Witherspoon R, Weiden P, Buckner CD (1993) High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy. J Clin Oncol 11:1329\u20131335","journal-title":"J Clin Oncol"},{"key":"1003_CR43","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V89.3.814","volume":"89","author":"AR Yuen","year":"1997","unstructured":"Yuen AR, Rosenberg SA, Hoppe RT, Halpern JD, Horning SJ (1997) Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin\u2019s disease. Blood 89:814\u2013822","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-004-1003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-004-1003-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-004-1003-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T21:42:14Z","timestamp":1586122934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-004-1003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,23]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1007\/s00277-004-1003-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,23]]}}}